Jean-Marie Ruiz

Suggest Changes
Learn More
Telaprevir and boceprevir, the two first hepatitis C virus (HCV) NS3 protease inhibitors (PIs), considerably increase rates of sustained virologic response in association with pegylated interferon(More)
  • 1